Last $7.03 USD
Change Today -0.14 / -1.95%
Volume 2.7M
ACHN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David P. Wright

Former President, Chief Operating Officer and Director, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

66--

Background*

Mr. David P. Wright served as Chief Executive Officer of PharmAthene, Inc., a wholly-owned subsidiary of PharmAthene US Corporation from July 2003 to May 2010, and served its President and since July 2003. Previously, Mr. Wright served as President and Chief Operating Officer of Genvec Inc. He joined Genvec Inc. in December 2002. He served as President and Chief Business Officer of Guilford Pharmaceuticals from February 2002 to December 2002, and served as its Executive ...

Read Full Background

Corporate Headquarters*

300 George Street
New Haven, Connecticut 06511

United States

Phone: 203-724-6000
Fax: 203-624-7003

Board Members Memberships*

Former President, Chief Business Officer and Director
Former Director
2003-N/A
Former President, Chief Operating Officer and Director
2007-2013
Former Director and Member of Audit Committee
2007-2010
Former Executive Director and Member of Government Affairs Committee

Education*

MA 1969
University of Florida

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $7.03 USD -0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.